William Tyler Frantz (William Frantz)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Transcription Factor

Signaling Pathway

Polycystic Kidney Disease

Top Venues

medRxiv : the preprint server for health sciences

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Esteban Javier Rozen, William Tyler Frantz, Kim Wigglesworth, Theadora Vessella, Hong Susan Zhou, Jason M Shohet
Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis. Molecular cancer therapeutics (2024)
Esteban Javier Rozen, William Tyler Frantz, Kim Wigglesworth, Theadora Vessella, Hong Susan Zhou, Jason M Shohet
Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis. Molecular cancer therapeutics 23 (8) (2024)
Abigail O Smith, William Tyler Frantz, Kenley M Preval, Yvonne J K Edwards, Yvonne J K Edwards, Julie A Jonassen, Gregory J Pazour
The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in pre-cystic epithelial cells revealing a new target for polycystic kidney disease. medRxiv : the preprint server for health sciences (2023)
Abigail O Smith, William Tyler Frantz, Kenley M Preval, Yvonne J K Edwards, Yvonne J K Edwards, Julie A Jonassen, Gregory J Pazour
The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in pre-cystic epithelial cells revealing a new target for polycystic kidney disease. medRxiv : the preprint server for health sciences (2023)
William Tyler Frantz, Sharanya Iyengar, James Neiswender, Alyssa Cousineau, René Maehr, Yvonne J K Edwards
Pigment cell progenitor heterogeneity and reiteration of developmental signaling underlie melanocyte regeneration in zebrafish. eLife 12 (2023)